More News! 10 Oct 2017
Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug
Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been
- Latest Posts
News and Trends 9 Oct 2017
British Scientists Regenerate Bone By Mimicking Nature
Nano-sized vesicles that are generated naturally during bone formation have the potential to regenerate bone, teeth and cartilage. Researchers from the University of Birmingham have mimicked the body’s natural healing process to repair damaged tissue, for example, bone. The study, which is published in Scientific Reports, has found that vesicles produced by stimulated cells outperform the […]
Interview 9 Oct 2017
The Woman Developing the Next Generation of Cancer Immunotherapy
Özlem Türeci discusses the future of individualized cancer therapy and her journey to become an entrepreneur and take science to patients. As a trained physician and immunologist, Dr. Özlem Türeci has led her own research group with Prof. Ugur Sahin at the University of Mainz, Germany, since 2000. But academic research was not enough for her, […]
News and Trends 7 Oct 2017
Mind the Gut: Copenhagen Exhibition Explores Bacteria and Feelings
The exhibition Mind the Gut at the Medical Museion in Copenhagen opens its doors to visitors to challenge the view of our own bodies. The Medical Museion in Copenhagen has expanded its exhibition area to make way for Mind the Gut, an exploration of the complex relationship between our brain and bowels through art, science, […]
News and Trends 6 Oct 2017
Study Reveals No Evidence to Support Most European Cancer Drug Approvals
A new study concludes the majority of cancer drugs approved by the EMA between 2009 and 2013 weren’t backed by sufficient evidence that they are effective. A team of researchers from King’s College London and the London School of Economics has published a new study reviewing the clinical data used to back the approval of […]
News and Trends 6 Oct 2017
British-Finnish Alliance to Bring Gene Therapy to the Masses
FIT Biotech and Avacta hope to combine their technologies to produce highly specific, best-in-class gene therapy treatments. The two companies have spotted an opportunity to bring together their technologies and form a leading gene therapy system in a market that could be worth over $4.3B (€3.7B) by 2024. FIT Biotech, based in Finland, has been working on […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 5 Oct 2017
Spanish Biotech’s Stock Surges After Decision to Move out of Barcelona
Oryzon Genomics announced it will move its headquarters from Barcelona to Madrid days after the Catalonian independence vote, making its stock grow by 30%. Oryzon Genomics, a Spanish biotech leveraging epigenetics to treat cancer, announced on Tuesday its decision to move out of Barcelona and establish its new headquarters in Madrid, citing the “optimization of […]
News and Trends 5 Oct 2017
British Biotech To Raise £12.2M to Finish Off Liquid Biopsy Technology
Angle will raise £12.2M, which will allow it to acquire assets from Axela to put the finishing touches to its full liquid biopsies solution. Angle is a leader in the liquid biopsy market, the ‘holy grail’ of cancer diagnostics. The company has developed technology that recently outperformed the gold standard in the field. Angle is hoping to raise £12.2M […]
News and Trends 5 Oct 2017
Dutch Clinical Trial Points to Fecal Transplant as Diabetes Treatment
A small clinical trial in the Netherlands has found that a fecal transplant from a lean donor can temporarily improve diabetes symptoms in obese men. Research published in Cell Metabolism from the University of Amsterdam has found that a fecal transplant from lean men to obese men can cause a short-term improvement in insulin resistance. This […]
News and Trends 5 Oct 2017
British Biotech Founder Receives the Nobel Prize in Chemistry 2017
Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology to discover new medicines. This year’s Nobel Prize in Chemistry has been awarded to Jacques Dubochet, Joachim Frank and Richard Henderson for the development of cryo-electron microscopy. This technology, now widely used in structural biology labs, is considered a stepping […]
News and Trends 5 Oct 2017
Synbio adds Softness: Robots of the Future will be Squishy
As AI and machine learning approach biotech, synthetic biology is approaching soft robotics. What is it bringing to the field? Conventional rigid-bodied robots are used to perform specific single tasks efficiently but often with limited adaptability when it comes to interacting with humans. During the past few years, soft robots made of highly pliable materials […]
News and Trends 4 Oct 2017
Ablynx Launches $175M IPO on Wall Street After Phase III Success
Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a $175M (€148M) IPO to continue developing its nanobodies technology. On Monday, the Belgian biotech shared the news that its nanobody, caplacizumab, received encouraging results for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP), a life-threatening blood disorder. This news boosted the company’s […]
ADVERTISEMENT
